Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01560663 | Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer | unknown | — | 415 | Miguel Martín JiménezOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT05912062 | Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer(BiOnHER) | unknown | — | 80 | Institut Català d'OncologiaOTHER |
| 1 |
| Sep 29, 2023 |
| clinicaltrials |
| NCT06061666 | Treatment of Insomnia in Patients With Breast Cancer | unknown | N/A | 80 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT06061835 | Non-contrast Magnetic Resonance Angiography in Deep Inferior Epigastric Perforator Flap Breast Reconstruction Planning | unknown | N/A | 135 | I.M. Sechenov First Moscow State Medical UniversityOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT03382340 | IMX-110 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 70 | Immix Biopharma Australia Pty LtdINDUSTRY | 2 | Sep 28, 2023 | clinicaltrials |
| NCT04883814 | 18F-fluoroestradiol (FES) PET/CT for Breast Cancer | unknown | Phase 2 | 124 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05024591 | Artificial Intelligence for breaST canceR scrEening in mAMmography (AI-STREAM) | unknown | — | 25,008 | Kyung Hee University Hospital at GangdongOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05174832 | Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients | unknown | Phase 2 | 136 | Fudan UniversityOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05800834 | Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds(MorphineGEL) | unknown | Phase 2 | 106 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Sep 28, 2023 | clinicaltrials |
| NCT06001528 | Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer | unknown | — | 2,400 | Shantou Central HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT03983577 | Efficacy of Point Of Service Testing in MBC(EPOST MBC) | unknown | N/A | 100 | University of Kansas Medical CenterOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT05296577 | Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer | unknown | Phase 2 | 134 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 25, 2023 | clinicaltrials |
| NCT05328440 | Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02) | unknown | Phase 2 | 120 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 25, 2023 | clinicaltrials |
| NCT06052085 | Investigation of the Efficiency of Pain Neuroscience Education in Patients With Chronic Pain After Breast Cancer Surgery | unknown | N/A | 50 | Hacettepe UniversityOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT03712956 | CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER | unknown | Phase 2 | 63 | European Institute of OncologyOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT04165993 | Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer | unknown | Phase 2 | 68 | Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06043661 | Early Detection of Breast Cancer | unknown | — | 700 | Datar Cancer Genetics IncINDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06046664 | Oncotype DX DCIS: Impact on Radiotherapy Decision Making(ONCOTYPE) | unknown | N/A | 78 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06046755 | Nutritional Intervention-induced Weight Loss During the Oncological Treatment of Obesity-related Breast Cancer(NUTOBREST) | unknown | N/A | 220 | Hospital Clinico Universitario de SantiagoOTHER | 0 | Sep 21, 2023 | clinicaltrials |
| NCT06040983 | Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing | unknown | N/A | 30 | China Medical University HospitalOTHER | 0 | Sep 18, 2023 | clinicaltrials |
| NCT05353361 | A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer | unknown | Phase 2 | 402 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Sep 15, 2023 | clinicaltrials |
| NCT05823623 | Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer | unknown | Phase 2 | 30 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT06010615 | Relative Dose Intensity of Adjuvant Chemotherapy in Older Women With ER+ HER2- Breast Cancer.(BREASTOLD) | unknown | — | 70 | Centre Hospitalier Universitaire de BesanconOTHER | 0 | Sep 7, 2023 | clinicaltrials |
| NCT05755048 | FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 3 | 314 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY | 1 | Sep 1, 2023 | clinicaltrials |
| NCT06015126 | Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients | unknown | N/A | 60 | Yan XueOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT05125991 | Evaluation of the Effectiveness of Prepectoral Breast Reconstruction | unknown | N/A | 58 | European Institute of OncologyOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT05923164 | Reliability And Validity Study Of "The Evaluation Tool For Myofascial Adhesions In Patients After Breast Cancer" In Turkish Language(MAP-BC) | unknown | — | 88 | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT06000033 | Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative, HER2-Low-Expressing Metastatic Breast Cancer | unknown | Phase 2 | 35 | Qilu Hospital of Shandong UniversityOTHER | 0 | Aug 21, 2023 | clinicaltrials |
| NCT05992441 | Awareness Scale Related To Physiotherapy After Breast Cancer: A Scale Development Study | unknown | — | 450 | Fenerbahce UniversityOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT03961698 | Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma(MARIO-3) | unknown | Phase 2 | 91 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05981716 | Young Breast Cancer Survivors Study(YBCSS) | unknown | — | 384 | University of South CarolinaOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05985187 | Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer. | unknown | Phase 3 | 412 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Aug 14, 2023 | clinicaltrials |
| NCT04547465 | 2D Speckle-tracking Echocardiography in Chemotherapy-induced Cardiomyopathy With Cardiovascular Risk Factors | unknown | — | 300 | Gia Dinh People HospitalOTHER | 1 | Aug 8, 2023 | clinicaltrials |
| NCT05837598 | Adapting the Tumor Board Model for Mental Illness and Cancer | unknown | N/A | 30 | Massachusetts General HospitalOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05975190 | Respiratory Training and Relaxation Techniques to Improve Adjuvant Radiation Therapy in DIBH in Breast Cancer(B-REST) | unknown | N/A | 108 | Technical University of MunichOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05845138 | A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression. | unknown | Phase 1 / Phase 2 | 116 | Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05967884 | PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer | unknown | Phase 2 | 20 | Ottawa Hospital Research InstituteOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT04967352 | Predicting Chronic Pain Following Breast Surgery | unknown | — | 500 | University of California, San DiegoOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05433480 | A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer | unknown | Phase 3 | 274 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05961111 | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05921279 | Understanding CARdiac Events in Breast Cancer(UCARE) | unknown | — | 100 | National University of Ireland, Galway, IrelandOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT05206396 | TIL Relation to pCR After Neoadjuvant Therapy in Breast Cancer Patients | unknown | — | 270 | Ain Shams UniversityOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05932758 | Excisional Vacuum-Assisted Breast Biopsy | unknown | N/A | 300 | European Institute of OncologyOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05953909 | A Study of Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01).(ERI-Based-01) | unknown | — | 120 | Fujian Cancer HospitalOTHER_GOV | 1 | Jul 20, 2023 | clinicaltrials |
| NCT05951699 | Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy | unknown | — | 105 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jul 19, 2023 | clinicaltrials |
| NCT05953168 | T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients | unknown | Phase 2 | 69 | Fudan UniversityOTHER | 1 | Jul 19, 2023 | clinicaltrials |
| NCT05945368 | A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC | unknown | Phase 2 | 78 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT05938686 | Home_Based Digital Mindful Dance Program for Breast Cancer Cases(Dance4BC) | unknown | N/A | 104 | National Yang Ming Chiao Tung UniversityOTHER | 1 | Jul 10, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Sep 29, 2023source: clinicaltrials